Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Theta Labs CEO Sued for Alleged Token Manipulation and Fraud

Theta Labs CEO Sued for Alleged Token Manipulation and Fraud

CryptotaleCryptotale2025/12/17 17:15
By:Cryptotale
  • Theta Labs former executives file lawsuits accusing CEO Mitch Liu of insider trading and fraud.
  • Legal battle raises concerns that could undermine investor confidence in THETA’s future.
  • The case highlights the need for stronger governance and accountability in crypto projects.

Two former senior executives of Theta Labs, Jerry Kowal and Andrea Berry, have filed lawsuits against the CEO, Mitch Liu. The lawsuits have been filed in the Los Angeles Superior Court, alleging that the CEO engaged in fraudulent practices such as insider trading, market manipulation, and retaliation against employees. 

The allegations have been made regarding the manipulation of the price of the THETA token, with the plaintiffs claiming that Liu had been following such practices to increase the value of the token.

Charges of Fraud and Market Manipulation

The lawsuit alleges that Liu exploited Theta Labs for personal gain through several deceptive means. As alleged in the lawsuits, Liu’s practices include insider trading, deceptive partnerships, and “pump-and-dump” schemes designed to drive up the price of THETA tokens.

Kowal and Berry also claim that Liu misled the value of THETA by making unsubstantiated claims of partnership, including one that was purportedly with Google Cloud. However, the lawsuit alleges that the partnership was misrepresented as strategic when, in fact, it was merely a cloud services agreement worth approximately $7 million.

The plaintiffs also accuse Liu of participating in insider trading in order to gain profits from the sale of tokens using private information. The plaintiffs also argue that Liu created fake bids for non-fungible tokens that are associated with top partnerships.

Alleged Retaliation Against Whistleblowers

Kowal and Berry further assert that Liu retaliated against workers who questioned his behavior. According to the lawsuits, anyone who attempted to expose the fraud was subsequently penalized, resulting in a culture of fear in the company. 

The plaintiffs argue that this retaliatory conduct contributed to a hostile work environment and suppressed any efforts to reveal the suspected wrongdoing.

Related: Do Kwon Sentenced to 15 Years as Terra Fraud Case Concludes

Reputation of Theta and Investor Concerns

The allegations have raised concerns among investors and the wider crypto community. Theta Labs, which is famous for building the Theta Network, primarily works on media distribution, storage, and computing. But the lawsuits have now brought the company’s practices into the limelight, further raising questions about its future growth prospects.

Investors are now left questioning the integrity of the project as well as its management. Misrepresentations about partnerships, especially between them and Google Cloud, may lead to a loss of credibility. Further scrutiny by regulators, particularly in light of the lawsuit, may also impact other cryptocurrency projects.

The price of the THETA token has already seen some volatility in reaction to the news of the lawsuits. Investors are now closely watching the case, as it may affect market sentiment and the future direction of Theta Labs.

The implications of the allegations may be of great concern to anyone holding an interest in the THETA token or being part of the Theta Network. One of the main principles of blockchain technology is decentralization and trustlessness, but the lawsuit shows that there may be a flaw in this notion at Theta Labs. 

This is likely to cause volatility in the price of THETA as the case develops. The market has historically been negative in reaction to the legal ambiguity, and this could lead to regulatory action against Theta Labs. Moreover, the developments in the case progress are likely to highlight the importance of more transparent and accountable leadership in the crypto community.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

U.S. non-farm payrolls surge by 165,000 in October, far exceeding expectations! Unemployment rate unexpectedly drops to 4.1%, December rate hike expectations intensify

In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.

华尔街见闻•2026/11/06 15:01

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23